Zentiva, a.s.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Zentiva, a.s..The latest application filed is for "method of preparation of n-(1-oxopentyl)-n-[[2'-(1h-tetrazol-5-y1) [1,1'-biphenyl]-4-y1]methyl]-l-valine (valsartan)".

Company Profile

0.9.12

Zentiva, a.s. - Hlohovec SK
Zentiva, a.s. - Praha CZ
Zentiva, A.S. - Praha 10 CZ
Zentiva, a.s. - CZ CZ
ZENTIVA, A.S. - Praha 10- Dolni Mecholupy CZ
Zentiva A.S. - Prague CZ
ZENTIVA , A.S. - U Kabelovny 130, Dolni Mecholupy Praha 10 CZ
ZENTIVA, A.S. - Nitrianska 100 Hlohovec SK
Zentiva, A.S. - Dolni Mecholupy 130 Praha 10 CZ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Method of preparation of oxycodone Grant 7,619,087 - Snuparek , et al. November 17, 2	2009-11-17
Amorphous forms of risedronate monosodium Grant 7,618,953 - Richter , et al. November 17, 2	2009-11-17
Method of preparation of N-(1-oxopentyl)-N-[[2'-(1H-tetrazol-5-y1) [1,1'-biphenyl]-4-y1]methyl]-L-valine (valsartan) App 20090192318 - Radl; Stanislav ; et al.	2009-07-30
Method of production of (-)-(S)-3-[1-(dimethylamino)ethyl]phenyl-N-ethyl-N-methylcarbamate Grant 7,544,840 - Stepankova , et al. June 9, 2	2009-06-09
Method Of Manufacturing (s)-n-methyl-3-(1-naphthyloxy)-3-(2-thienyl)propylamine Hydrochloride (duloxetine) App 20090143600 - Ridvan; Ludek ; et al.	2009-06-04
Process for preparation of carvedilol Grant 7,534,895 - Hercek , et al. May 19, 2	2009-05-19
Method of Preparation of (R)-(-)-5(2-Aminopropyl)-2-Methoxybenzenesulfonamide App 20080319225 - Hajicek; Josef ; et al.	2008-12-25
Methods For the Stabilization of Atorvastatin App 20080171784 - Sebek; Pavel ; et al.	2008-07-17
Method of manufacturing glimepiride and the respective intermediate Grant 7,282,517 - Radl , et al. October 16, 2	2007-10-16
Crystalline form of the sodium salt of 3-pyridyl-1-hydroxyethylidene-1,1-bisphosphonic acid Grant 7,276,604 - Richter , et al. October 2, 2	2007-10-02
Method of preparation of the hemi-calcium salt of (e)-7-[4-(4fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonvl)aminolpyrim- idin-5-yl](3r,5s)-3,5-, dihvdroxy-6-heptenoic acid App 20070155765 - Sebek; Pavel ; et al.	2007-07-05
Amorphous forms of risedronate monosodium App 20070142332 - Richter; Jindrich ; et al.	2007-06-21
Method of manufacturing an amorphous form of the hemi-calcium salt of (3R,5R) 7-3-phenyl-4-phenylcarbamoyl-2-(4-fluorophenyl)-5-isopropyl-pyrro- l-1-yll-3, 5-dihydroxyheptanoic acid (actorvastatin) Grant 7,208,608 - Radl , et al. April 24, 2	2007-04-24
Method of preparation of oxycodone App 20070088162 - Snuparek; Vladislav ; et al.	2007-04-19
Tablet obtained by direct compression comprising 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid as active ingredient Grant 7,198,802 - Jasprova April 3, 2	2007-04-03
Process for preparation of carvedilol App 20060167077 - Hercek; Richard ; et al.	2006-07-27
New crystalline form of the sodium salt of 3-pyridyl-1-hydroxyehtylidene-1,1-bisphosphonic acid App 20060148762 - Richter; Jindrich ; et al.	2006-07-06
Method of production of (-)-(s)-3-[1-(dimethylamino)ethyl]phenyl-n-ethyl-n-methylcarbamate App 20060122417 - Stepankova; Hana ; et al.	2006-06-08
Method for obtaining pioglitazone as an antidiabetic agent Grant 7,009,057 - Halama , et al. March 7, 2	2006-03-07
Method for manufacturing crystalline form I of clopidogrel hydrogen sulphate App 20060041136 - Veverka; Miroshlav ; et al.	2006-02-23
Process for the preparation of zaleplon App 20050245742 - Radl, Stanislav	2005-11-03

Company Registrations

NCAGE Code	1129M	ZENTIVA, A.S.
CAGE Code	1129M	ZENTIVA, A.S.

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.